Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis.
Biochem Biophys Res Commun
; 623: 59-65, 2022 10 01.
Article
in En
| MEDLINE
| ID: mdl-35872543
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atherosclerosis
/
Lipoproteins, LDL
Limits:
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2022
Type:
Article
Affiliation country:
India